Research on new and better ways to treat cancer. Covers radiotherapy, targeted microdroplets, nerve-injury protection, drug combinations, and tumor models.
Mayo Clinic researchers found that baseline quality of life is a strong predictor of survival in cancer patients, with scores above 83 associated with increased survival time. The study suggests that identifying quality of life deficits can help physicians intervene and improve patient outcomes, potentially extending their length of life.
Collaboration between physicians and dentists is essential for improving the early detection and treatment of patients with osteoporosis. Oral health maintenance plays a vital role in managing osteoporosis, and healthcare professionals should discuss patient care decisions with the physician.
A study published in Clinical Cancer Research found that genetic polymorphisms are associated with a lower risk of prostate cancer among Hispanic men. The research suggests that these genetic variations may help clinicians predict who is more likely to develop the disease, potentially reducing unnecessary screenings and treatments.
Researchers found a 27% reduced incidence of prostate cancer in mice on a low-fat diet compared to those on a Western-style diet. The study suggests that lowering dietary fat intake may slow the growth of precancerous cells and prevent prostate cancer development.
A mutated form of p53 can become stable in some cells, facilitating cancer formation and metastasis. Targeted therapies aimed at activating wild-type p53 may also stabilize mutant p53, disrupting their effectiveness.
A rare post-endoscopic retrograde cholangiopancreatography (ERCP) pneumoperitoneum case was reported, resulting from a large peripheral hepatic metastasis rupture. The patient was successfully managed conservatively with close clinical and radiological surveillance.
A study found that a 10-day triple therapy regimen was more effective in eradicating H. pylori and reducing gastric inflammation than a 7-day regimen. However, non-compliance was higher in the 10-day group, highlighting the need for cost-benefit analysis in treatment decisions.
A rare case of extrahepatic bile duct cancer producing granulocyte colony-stimulating factor (G-CSF) has been reported, highlighting the need for early diagnosis and treatment. The discovery raises concerns about the potential impact on prognosis and treatment options.
The study found that long-term etanercept therapy resulted in significant improvement in joint symptoms, functional ability, and pain reduction for children with JRA. The treatment demonstrated safety comparable to other rheumatic disorders, offering hope for a better quality of life as adults.
Researchers at the University of Helsinki have identified a novel mechanism by which harmless colon polyps acquire malignant tumor properties, driven by abnormal PROX1 protein production. Removing PROX1 from cancer cells reverses their malignant behavior, suggesting it as a promising target for future therapies.
Researchers found that EGFR stabilizes sodium/glucose transporter 1 to maintain adequate glucose levels in cancer cells, preventing autophagic cell death. This study suggests that inhibiting both EGFR-mediated SGLT1 stabilization and EGFR kinase activity may be necessary for eradicating epithelial tumors.
Treatment advances for fibroids and endometriosis aim to preserve reproductive potential while treating these conditions. Novel conservative approaches, including medical treatments and non-invasive procedures, are now available, offering women more choices during menopause.
A new ultrasensitive assay developed by City of Hope and California Department of Public Health can detect botulinum neurotoxin with high accuracy, improving food safety and diagnosis. The test is ten thousand times more sensitive than current methods and has potential applications in diagnosing other diseases.
Researchers found that restoring two small molecules in human chronic lymphocytic leukemia cells can block tumor growth and affect 70 genes involved in critical functions. These findings suggest a possible new treatment strategy for CLL.
A new method developed by Murali Krishna and colleagues at the National Institutes of Health uses low-field paramagnetic resonance imaging to image tumors and surrounding organs in mice. This approach has shown promise for determining the best treatment approach for tumors and other diseases, as well as monitoring responses to treatment.
A prostate cancer screening program introduced in the Tyrol region of Austria led to a significant reduction in deaths from the disease, with a 54% decline by 2005. The program's success can be attributed to early detection and effective treatment, which has improved patient outcomes.
A study found that aromatase inhibitors (AIs) do not increase the risk of heart problems in women who take them, contrary to previous fears. The research suggests AIs are superior to tamoxifen in reducing breast cancer recurrence and do not significantly worsen cardiovascular health.
Researchers at Dana-Farber Cancer Institute report the first case of metastatic melanoma driven into remission by a targeted therapy. A 79-year-old woman with abdominal tumors was treated with Gleevec (Imatinib) after lab tests revealed an abnormality in the KIT gene.
Research reveals a striking decline in US prostate cancer mortality compared to the UK, with faster rates of decline attributed to increased screening and treatment. The study suggests that differences in detection and treatment policies may contribute to this disparity.
Researchers at the University of Chicago Medical Center have discovered a novel genetic marker, H2A.Z, linked to breast cancer progression and metastasis. Elevated expression of this protein can help physicians make better predictions and treatment choices for patients.
Researchers found that lung cancer patients over 80 fare equally well after surgery as their younger counterparts, while elevated interleukin-12 levels are associated with poorer survival rates in melanoma patients. DNA methylation decreases with age, potentially contributing to cancer development.
A tracking system helped improve rates of medical oncology consultation and reduce disparities in breast cancer treatment by notifying surgeons when their patients visited an oncologist. The new system also eliminated racial disparity in treatment, as minority women were less likely to receive underuse of adjuvant therapy.
Researchers found that sunitinib treatment slowed tumor growth and reduced the risk of metastasis in patients with advanced hepatocellular carcinoma. The median progression-free survival was four months, and the median overall survival was 10 months.
A new study shows that MRI and PET/CT can triage patients with stage 1B cervical cancer to optimal first-line therapy, preventing unnecessary trimodality therapy. The combination of both imaging modalities results in a 95% reduction in patients being triaged to high-morbidity treatment.
Researchers have validated genetic aberrations and identified new targets for GBM treatment. A novel regulatory circuit involving INK4 family genes, p18INK4C and p16INK4A, constrains inappropriate glial cell proliferation and enhances tumorigenicity.
A new study presented at the Experimental Biology Annual Meeting shows that Dermytol produces a significant reduction in malignant melanoma cell growth. The compound has demonstrated potential in reducing damage to skin cells and may be used in anti-aging and sun-protection products.
A comprehensive review of breast cancer research identifies key gaps in treatment and patient care, calling for increased attention on prevention, detection, and spread. The charity Breast Cancer Campaign is already funding innovative projects to fill these gaps and improve survival rates.
A new study has found that hormone replacement therapy (HRT) increases the risk of breast cancer recurrence in women who have survived breast cancer. The HABITS trial, which followed over 200 breast cancer survivors for four years, found that HRT significantly increased the risk of disease recurrence.
Researchers found that only about 45% of cases used tumor markers AFP and HCG, with all three markers measured in just 16% of the time. This suggests low usage rates despite the importance of tumor markers in showing patient response to treatment and disease recurrence.
A gene therapy treatment has been developed to restore a missing liver enzyme in people with glycogen storage disease type Ia (GSD-Ia). The treatment has shown promising results in animal studies, with protected blood glucose levels for up to a year. Further research is needed to test the safety and efficacy of the treatment in humans.
The American Association for Cancer Research (AACR) provides financial support to 10 undergraduate students through the AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students. The program allows students to present research, learn from educational sessions and symposia, and network with experts in the field.
A nationwide study in the Netherlands found that women diagnosed with early-stage ovarian cancer treated at semispecialized or specialized hospitals survived longer than those treated at general hospitals. The estimated five-year survival improved with increasing specialization of the treatment facility, from 38% to 40.3%.
The Burroughs Wellcome Fund has awarded $9.75 million to 13 translational researchers through its Clinical Scientist Awards in Translational Research. These awards support established physician-scientists exploring scientific questions, applying knowledge at the bedside, and bringing insights back to the laboratory.
Research found that indoor tanning is a concern for all age groups, with 20% of 18-39 year olds and 10% of 50-64 year olds tanning indoors. Older adults who tan indoors have higher skin cancer risk due to cumulative exposure.
Researchers have created a highly accurate mouse model of inflammatory bowel disease (IBD), which closely resembles the most serious form of human ulcerative colitis. Treating the mice with broad-spectrum antibiotics reduced gut inflammation and increased survival, providing hope for new treatments.
A recent study by the University of Pennsylvania School of Medicine found that curcumin, an active ingredient in turmeric, had a low response rate in patients with psoriasis. Despite laboratory evidence showing its potential, the study suggests that the placebo effect or natural remission may be responsible for the limited results.
A concentrated broccoli sprouts extract cut bladder tumor development in animal models, with isothyiocyanates delivering potent protective action. The study's results reinforce associations between cruciferous vegetable intake and reduced bladder cancer risk.
A Dutch study found that only 17% of individuals who survive pediatric cancer receive follow-up care at age 35, highlighting the need for family doctors to be involved. The study suggests that shared care between dedicated clinics and family practitioners can increase surveillance for adverse effects.
A new study finds that women with higher levels of perceived stress are more likely to have an impaired immune response to HPV16, increasing their risk of developing cervical cancer. Most HPV infections in healthy women will disappear spontaneously over time.
Researchers have identified a key role for a glaucoma gene, sFRP1, in the development of the disease, which causes high pressure in the eye. Over-expression of this gene disrupts the WNT-signaling pathway, leading to elevated intraocular pressure and vision loss.
Researchers at the University of Granada have found that maslinic acid, a compound present in olive skin wax, has anti-cancer properties. The compound regulates cell growth and is selective in its action on carcinogenic cells.
A study published in the Journal of the National Cancer Institute found that HPV-positive head and neck cancer patients have higher response rates to chemoradiation therapy and better two-year overall survival rates compared to HPV-negative patients.
A new molecular signature predicts response to lenalidomide in patients with myelodysplastic syndrome without chromosome 5q deletions. Gene expression profiling identifies a defect in erythroid differentiation, providing potential treatment insights.
Researchers found that STAT3 has tumor-promoting and tumor-suppressing effects depending on the genetic profile of glioblastoma tumors. This discovery highlights the need for effective therapies tailored to individual glioblastoma tumors.
A study suggests that endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and its combination with endobronchial ultrasound-guided fine-needle aspiration (EBUS-FNA) can accurately determine lung cancer stage. These minimally invasive methods show high sensitivity rates, potentially replacing traditional surgical procedures.
Researchers have developed a successful test vaccine that prevents the development of prostate cancer in 90% of young mice. The vaccine targets prostate stem cell antigen (PSCA), which is over-expressed in early-stage prostate cancers, and has been shown to mount an immune response against the protein.
A new urine test detects prostate cancer more accurately than current methods, including PSA and PCA3 tests. The test identified 80% of patients with prostate cancer and was 61% effective in ruling out disease.
A study by Dr. Catherine Sabiston found that breast cancer survivors who participated in dragon boat racing reported significantly improved physical and mental health. The social aspect of the activity provided a sense of community and empowerment, helping women cope with post-recovery trauma.
Dr. Vivian Cheung, a pediatric neurologist at Children's Hospital of Philadelphia, has been selected as a Howard Hughes Medical Institute Investigator. Her research focuses on translating genetic discoveries into improved medical treatments by analyzing gene expression and its association with disease susceptibility.
Researchers found that self-expanding plastic stents (SEPSs) resulted in frequent stent migration, with over 60% of patients experiencing this issue. Long-term symptom improvement was also limited, with only six percent of procedures resulting in long-term resolution.
Researchers at German Cancer Research Center discovered a new molecule Akirin that plays a crucial role in triggering the innate immune response in fruit flies, mice, and humans. Inhibiting this pathway may lead to new cancer treatments.
A recent study by Children's Hospital of Pittsburgh found that adolescents and young adults with cancer are less likely to be enrolled in clinical trials for cutting-edge treatments. This can lead to lower survival rates compared to younger children, who have seen significant improvements in cure rates over the past 30 years.
Children of BRCA mutation carriers are more likely to support genetic testing, despite potential risks and benefits. A study found that 40% of parents and their adult offspring supported testing minors, with half in favor only in certain circumstances.
Nucleonics has initiated a Phase 1 human safety study of its experimental treatment NUC B1000, an expressed interfering RNA-based product designed to target and destroy HBV within infected cells. The therapy aims to reduce viral antigen load and potentially resolve viral infection in patients with mild to moderate disease.
Researchers found that 77% of methadone users with low levels had no significant cardiac abnormalities, while 60% of non-methadone users had identifiable evidence of cardiac disease. The study suggests a link between methadone and sudden cardiac death, potentially necessitating additional safeguards before therapy.
Researchers found that sirolimus reduced angiomyolipoma size by nearly 50% in TSC and LAM patients. Lung function also improved in LAM patients, with a 10-15% increase in expiratory air flow.
Researchers discovered that a transient and local rise in interleukin-6 (IL-6) is essential for the growth of muscle fibers. This finding could lead to new treatments for reversing or improving muscle loss in diseases such as cancer and AIDS, as well as normal aging.
A new study by Fox Chase Cancer Center reveals that most American adults engage in multiple behaviors increasing their exposure to UV rays, including infrequent sun protection and indoor tanning. The study found that younger adults, men, Caucasians, smokers, and those with fair skin are more likely to engage in these high-risk behaviors.
Cancer risk increases with age, yet elderly nursing home residents receive relatively few cancer care services. According to a recent study, only 28% of patients with late-stage cancer received hospice care, highlighting the need for further investigation into cancer care in this population.
Bevacizumab plus interferon improves progression-free survival in patients with metastatic renal cell carcinoma compared to interferon alone. The new treatment option is expected to provide a better prognosis for patients with renal cancer.